associated with disease. Recently, extracellular vesicles (EVs) have emerged as mediators of intercellular communication. There is however very little known about the pathophysiological role of EVs in musculoskeletal diseases. In this study, we investigate whether plasma EVs from OA patients can drive chondrocyte terminal differentiation, a pathophysiological process observed in affected joints and a hallmark of OA. Objectives Study the effect of plasma-derived EVs from OA patients during chondrogenenic differentiation of mesenchymal stem cells. Methods Plasma-derived extracellular vesicles (pEVs) were isolated from plasma of OA patients and age-matched healthy controls using size-exclusion chromatography. EV containing fractions were characterised according to ISEV guidelines.
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EPIGENETIC CONTROL OF DISTALLY EXPRESSED HOXD GENES IN SYNOVIAL FIBROBLASTS
Introduction Synovial fibroblasts (SF) from different joint localizations exhibit profound differences in their expression profiles that might predispose specific joints for certain forms of arthritis. 1 Homeobox (HOX) genes were shown to play important roles in limb development and might influence the site-specific development of various diseases. Objectives To analyse the expression of distally expressed HOXD genes in SF from hands and to investigate their epigenetic regulation. Methods The expression of HOXD10, HOXD11 and HOXD13 was analysed by quantitative Real-time PCR. The histone marks H3K4me1 (enhancers), H3K4me3 (transcriptional starts of transcribed genes), H3K27me3 (inactive gene promoters) and H3K27ac (active enhancers) in SF from one RA (finger) and one osteoarthritis (OA; thumb) patient were analysed by ChIP DNA sequencing (ChIPseq). Hand SF (n=7) were treated for 24 hour with the bromodomain inhibitor I-BET151 (1 mM), targeting the bromodomain and extra-terminal domain (BET) proteins. The expression of the histone-acetyltransferases CREBBP-binding protein (CBP) and p300 was silenced by transfection of antisense LNA gapmeRs in hand SF (n=4). Results HOXD10, HOXD11 and HOXD13 transcripts were significantly increased in SF from RA and OA patients in digits II-IV and wrists compared to SF from digit I (thumb). Accordingly, ChIPseq showed an increase of H3K27ac and H3K4me3 marks in the genomic region between HOXD9 and HOXD13 in SF from a RA finger compared to SF from an OA thumb, paralleled by a loss of the repressive histone marks H3K27me3 between HOXD12 and MIR10B. Treatment of SF with I-BET151 reduced the expression of HOXD10, HOXD11 and HOXD13 by 50% (±23; p<0.001), 29% (±29; p<0.05), and 27% (±27; p<0.05) respectively. Silencing of CBP reduced the expression of HOXD10 by 47% (±10; p<0.01) and HOXD11 by 22% (±19; p=0.1) but not HOXD13. Also silencing of p300 reduced the expression of HOXD10 by 47% (±24; p=0.06) and HOXD11 by 55% (±10; p<0.01) but not HOXD13. Conclusions Distally expressed HOXD genes exhibit site-specific expression between digits II-IV and the thumb. The sitespecific expression is maintained by a specific set of histone modifications and regulated by epigenetic writer (CBP, p300) and reader proteins (BET proteins). This epigenetically regulated expression of HOXD genes might influence the different occurrence of RA and OA in the small joints of the digits II-IV and the thumb.
